Carfilzomib, dexamethasone and daratumumab in relapsed or refractory multiple myeloma: results of the phase III study CANDOR by prior lines of therapy

Subjects

Subjects :

Oncology
medicine.medical_specialty
Hematology
Bortezomib
business.industry
Cancer
Daratumumab
medicine.disease
Carfilzomib
chemistry.chemical_compound
chemistry
Internal medicine
medicine
business
Dexamethasone
Multiple myeloma
medicine.drug
Lenalidomide

Details

ISSN :

13652141 and 00071048

Volume :

194

Database :

OpenAIRE

Journal :

British Journal of Haematology

Accession number :

edsair.doi...........a6cb425c4c354bcb59de8b45ea093567

Full Text :

https://doi.org/10.1111/bjh.17541